Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study
Launched by KANSAS CITY HEART RHYTHM RESEARCH FOUNDATION · Feb 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ADiPOSE Study is a clinical trial that looks at how common autonomic dysfunction (AD) is in people who have had bariatric surgery, such as gastric bypass or sleeve gastrectomy. Autonomic dysfunction can cause symptoms like feeling dizzy when standing up, known as orthostatic intolerance. The study aims to understand how this condition affects patients after their surgery and to learn more about the reasons behind it.
To participate, individuals must be between 18 and 85 years old, able to provide consent, and have undergone or are planning to undergo specific types of bariatric surgery. Participants will either have had the surgery within the last three years or will have it soon. The study is currently recruiting participants, and those who join can expect to share their experiences and health outcomes related to autonomic dysfunction with the research team. This information will help improve our understanding of how bariatric surgery impacts the nervous system and may lead to better care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the age of 18 - 85 years
- • Can provide consent
- • Negative urine B-hCG
- • Continued follow-up with the bariatric surgery team.
- • BS includes one of the following: gastric bypass, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch.
- • Phase I: Underwent BS within the last 3 years
- • Phase II: Will undergo BS within the next 3 months or underwent BS in the last 30 days
- Exclusion Criteria:
- • Unable to provide consent
- • Pregnant or breastfeeding
- • BMI \< 35
- • Revision surgery of one of the following BS from above
- • Prior history of autonomic dysfunction prior to BS
- • Developed AD 72 months post-procedure
- • No evidence of AD/OI
About Kansas City Heart Rhythm Research Foundation
The Kansas City Heart Rhythm Research Foundation is a leading clinical research organization dedicated to advancing the understanding and treatment of heart rhythm disorders. With a focus on innovative research methodologies and patient-centered care, the foundation conducts rigorous clinical trials aimed at improving therapeutic options for patients with arrhythmias. Committed to collaboration with healthcare professionals and leveraging cutting-edge technology, the foundation strives to enhance clinical outcomes and contribute to the development of evidence-based practices in cardiology. Through its initiatives, the Kansas City Heart Rhythm Research Foundation plays a vital role in shaping the future of heart rhythm management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Overland Park, Kansas, United States
Overland Park, Kansas, United States
Independence, Missouri, United States
Independence, Missouri, United States
Kansas City, Missouri, United States
Kansas City, Missouri, United States
Overland Park, Kansas, United States
Overland Park, Kansas, United States
Patients applied
Trial Officials
Dhanunjaya Lakkireddy
Principal Investigator
Kansas City Heart Rhythm Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported